Cintas (NASDAQ:CTAS) PT Raised to $236.00 at The Goldman Sachs Group
Cintas (NASDAQ:CTAS – Get Free Report) had its price target lifted by research analysts at The Goldman Sachs Group from $212.00 to $236.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the business services provider’s stock. The Goldman Sachs Group’s target price would indicate a potential upside […]
More Stories
Insider Selling: Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) CAO Sells 2,352 Shares of Stock
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) CAO Carrie Liao sold 2,352 shares of the firm’s stock in...
ChargePoint Holdings, Inc. (NYSE:CHPT) Insider Sells $18,037.35 in Stock
ChargePoint Holdings, Inc. (NYSE:CHPT – Get Free Report) insider Jagdeep Ca Singh sold 13,361 shares of the business’s stock in...
Kiril Mugerman Purchases 150,000 Shares of Geomega Resources Inc. (CVE:GMA) Stock
Geomega Resources Inc. (CVE:GMA – Get Free Report) Director Kiril Mugerman acquired 150,000 shares of the business’s stock in a...
Analyzing Scinai Immunotherapeutics (NASDAQ:SCNI) & Mesoblast (NASDAQ:MESO)
Mesoblast (NASDAQ:MESO – Get Free Report) and Scinai Immunotherapeutics (NASDAQ:SCNI – Get Free Report) are both small-cap medical companies, but...
Strategic Equity Capital (SEC) to Issue Dividend of GBX 3.50 on November 13th
Strategic Equity Capital (LON:SEC – Get Free Report) announced a dividend on Thursday, September 26th, Upcoming.Co.Uk reports. Shareholders of record...
Sphere 3D Corp. (NASDAQ:ANY) Sees Large Drop in Short Interest
Sphere 3D Corp. (NASDAQ:ANY – Get Free Report) was the target of a large decrease in short interest in September....